Credit Agricole’s Novo Nordisk NVO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$26.6M Sell
555,000
-50,000
-8% -$2.15M 0.05% 265
2026
Q1
$22.2M Buy
605,000
+474,000
+362% +$22.5M 0.06% 248
2025
Q4
$6.67M Buy
131,000
+81,000
+162% +$4.14M 0.02% 521
2025
Q3
$2.77M Buy
+50,000
New +$2.93M 0.01% 718
2025
Q1
$3.47M Buy
+50,000
New +$4.13M 0.01% 616

Other funds holding NVO

Credit Agricole's NVO Position: Q2 2026 in Review

Credit Agricole reduced its Novo Nordisk (NVO) stake by 19% in Q2 2026, selling an estimated $2.9M and leaving 290,612 shares worth $13.9M. The position accounts for 0.03% of the portfolio, ranked #415.

Credit Agricole first reported a position in NVO in Q3 2015 and has held it in 10 quarters since. The position peaked at $21.9M in Q4 2025. 1,353 funds tracked by Wall St. Rank hold NVO as of Q2 2026.

  • Credit Agricole held 290,612 shares of Novo Nordisk worth $13.9M as of Q2 2026.
  • Credit Agricole sold 67,525 Novo Nordisk shares in Q2 2026, an estimated $2.9M.
  • Novo Nordisk made up 0.03% of Credit Agricole's portfolio in Q2 2026, its #415 holding.
  • Credit Agricole first reported a position in Novo Nordisk in Q3 2015 and has held it in 10 quarters since.
  • Credit Agricole's Novo Nordisk position peaked at $21.9M in Q4 2025.
  • 1,353 funds tracked by Wall St. Rank held Novo Nordisk as of Q2 2026.

Based on Credit Agricole's 13F filing for Q2 2026, filed 14 Aug 2026.